Epsilon M&A Deal Report - Alban Muller International

Transaction Multiples for the Valuation of Private Companies

Croda International > Alban Muller International

Announced Date : 02 March 2021

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Croda International

Target: Alban Muller International

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 1978, Alban Muller specialises in creating and suppling natural and botanical ingred ...

No EMAT : 104406

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1235

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
14/11/2020	Private Group Led By Cardinal Capital Group	Mowlam Healthcare	Ireland	*
30/09/2020	Atrys Health	Instituto Estudios Celulares y Moleculares	Spain	***

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database